73 results
Page 2 of 4
8-K
EX-2.6
a6zjh2
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-10.1
8eucspabfl0jj
18 May 22
Termination of a Material Definitive Agreement
4:06pm
8-K
EX-10.1
v5f4 d5yikpuqefw6
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
1obd93913wt4f51s
17 May 21
Regulation FD Disclosure
5:03pm
8-K
EX-1.1
qd9pnp u92
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K/A
EX-99.1
knth 7htbxoj5
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
99gkm
3 Feb 21
Other Events
4:59pm
D
cwydv 2k69balw
6 Jan 21
$33.6M in equity, sold $33.6M, 16 investors
5:28pm
8-K
EX-10.1
ym2c8
15 Dec 20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
7:34am
425
EX-10.1
471629
15 Dec 20
Business combination disclosure
7:32am
424B3
6phu1981n
12 Nov 20
Prospectus supplement
6:08am